Clinical Trials List
Protocol NumberMDCO-PCS-17-02 (CKJX839A12302)
2019-02-06 - 2021-09-09
Phase III
Terminated1
ICD-10E78.0
Pure hypercholesterolemia
ICD-9272.0
Pure hypercholesterolemia
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Dau-Ming Niu Division of Pediatrics
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
4 participants
-
Global
45 participants
